High replicative full-length lamivudine-resistant hepatitis B virus isolated during acute exacerbations.
J Med Virol. 2005.
PMID: 16121368
Search Page
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 1998 | 1 |
| 1999 | 2 |
| 2000 | 6 |
| 2001 | 7 |
| 2002 | 17 |
| 2003 | 15 |
| 2004 | 20 |
| 2005 | 12 |
| 2006 | 15 |
| 2007 | 4 |
| 2008 | 7 |
| 2009 | 5 |
| 2010 | 6 |
| 2011 | 10 |
| 2012 | 5 |
| 2013 | 5 |
| 2014 | 6 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2024 | 0 |
Search Results
146 results
Results by year
Citations
3
articles
found by citation matching
[Lamivudine for the prevention of chronic hepatitis B exacerbations during chemotherapy for non-Hodgkin's lymphoma].
Ned Tijdschr Geneeskd. 2002.
PMID: 12092307
Dutch.
Search results
Page 1
Chronic Hepatitis B Infection: A Review.
JAMA. 2018 May 1;319(17):1802-1813. doi: 10.1001/jama.2018.3795.
JAMA. 2018.
PMID: 29715359
Review.
IMPORTANCE: More than 240 million individuals worldwide are infected with chronic hepatitis B virus (HBV). Among individuals with chronic HBV infection who are untreated, 15% to 40% progress to cirrhosis, which may lead to liver failure and liver cancer. ...Long-ter …
IMPORTANCE: More than 240 million individuals worldwide are infected with chronic hepatitis B virus (HBV). Among individuals w …
Efficacy and Safety of Lamivudine Versus Entecavir for Treating Chronic Hepatitis B Virus-related Acute Exacerbation and Acute-on-Chronic Liver Failure: A Systematic Review and Meta-Analysis.
J Clin Gastroenterol. 2017 Jul;51(6):539-547. doi: 10.1097/MCG.0000000000000675.
J Clin Gastroenterol. 2017.
PMID: 28067752
Review.
BACKGROUND: Oral nucleos(t)ide analogs are recommended for patients with chronic hepatitis B virus (HBV)-related acute exacerbation (AE) and acute-on-chronic liver failure (ACLF). The efficacy and safety of administering entecavir (ETV) and lamivudine …
BACKGROUND: Oral nucleos(t)ide analogs are recommended for patients with chronic hepatitis B virus (HBV)-related acute exac …
Antiviral resistance and hepatitis B therapy.
Hepatology. 2009 May;49(5 Suppl):S174-84. doi: 10.1002/hep.22900.
Hepatology. 2009.
PMID: 19399794
Free PMC article.
The management of chronic hepatitis B currently rests with long-term therapy using oral nucleoside analogs. ...Antiviral resistance is due to the high rate of mutations that can occur during hepatitis B virus (HBV) replication and the selection of thes …
The management of chronic hepatitis B currently rests with long-term therapy using oral nucleoside analogs. ...Antiviral resis …
Impact of immunosuppression and chemotherapy on reactivation of viral hepatitis.
Saudi J Kidney Dis Transpl. 2010 Jul;21(4):621-7.
Saudi J Kidney Dis Transpl. 2010.
PMID: 20587863
Review.
Before starting chemotherapy, it is recommended to record the past history of liver disease and check for hepatitis B virus (HBV) and hepatitis C virus (HCV) serology. In immunosuppressed patients, radiation toxicity, graft versus host disease, hepatic veno-occlusiv …
Before starting chemotherapy, it is recommended to record the past history of liver disease and check for hepatitis B virus (H …
Severe acute exacerbation of chronic hepatitis B: a unique presentation of a common disease.
J Gastroenterol Hepatol. 2009 Jul;24(7):1179-86. doi: 10.1111/j.1440-1746.2009.05924.x.
J Gastroenterol Hepatol. 2009.
PMID: 19682192
Review.
This condition should be differentiated from acute hepatitis B and other causes of acute hepatitis must be excluded. Conventional prognostic systems may not be applicable to severe acute exacerbation of chronic hepatitis B. ...However, patients …
This condition should be differentiated from acute hepatitis B and other causes of acute hepatitis must be excluded. Conventio …
Hepatitis B viral genotypes: clinical relevance and molecular characteristics.
J Gastroenterol Hepatol. 2002 Jun;17(6):643-50. doi: 10.1046/j.1440-1746.2002.02737.x.
J Gastroenterol Hepatol. 2002.
PMID: 12100608
Review.
Hepatitis B virus (HBV) infection is a global health problem and the clinical outcome of chronic HBV infection depends on the frequency and severity of hepatitis flares in the immune clearance phase. ...Similarly, genotype D is associated with more severe liver dise …
Hepatitis B virus (HBV) infection is a global health problem and the clinical outcome of chronic HBV infection depends on the …
Hepatitis B virus infection: pathogenesis, reactivation and management in hematopoietic stem cell transplant recipients.
Expert Rev Anti Infect Ther. 2011 Oct;9(10):891-9. doi: 10.1586/eri.11.105.
Expert Rev Anti Infect Ther. 2011.
PMID: 21973301
Review.
Hepatitis B virus (HBV) is a partially double stranded DNA virus that can integrate into host cell chromosomes as covalently closed circular DNA forms. HBV reactivation following hematopoietic stem cell transplantation in recipients with evidence of past HBV exposur …
Hepatitis B virus (HBV) is a partially double stranded DNA virus that can integrate into host cell chromosomes as covalently c …
Tenofovir, entecavir, and lamivudine in patients with severe acute exacerbation and hepatic decompensation of chronic hepatitis B.
Dig Liver Dis. 2018 Feb;50(2):163-167. doi: 10.1016/j.dld.2017.10.002. Epub 2017 Oct 28.
Dig Liver Dis. 2018.
PMID: 29089265
OBJECTIVE: To compare the efficacy of and mortality after lamivudine (LAM), tenofovir (TDF), and entecavir (ETV) treatment in patients with severe acute chronic hepatitis B (CHB) exacerbation. METHODS: We analyzed 91 patients with severe acute CHB e …
OBJECTIVE: To compare the efficacy of and mortality after lamivudine (LAM), tenofovir (TDF), and entecavir (ETV) treatment in patient …
Randomized Controlled Study of Tenofovir versus Lamivudine Followed by Tenofovir in Severe Exacerbation of Hepatitis B.
Antimicrob Agents Chemother. 2022 Feb 15;66(2):e0166421. doi: 10.1128/AAC.01664-21. Epub 2021 Nov 22.
Antimicrob Agents Chemother. 2022.
PMID: 34807763
Free PMC article.
Clinical Trial.
Spontaneous severe acute exacerbation (SAE) is not uncommon in the natural history of chronic hepatitis B (CHB). Lamivudine (LAM) has the advantages of low price, quick onset, good efficacy, and no drug resistance within 24 weeks. ...
Spontaneous severe acute exacerbation (SAE) is not uncommon in the natural history of chronic hepatitis B (CHB). Lam …
Tenofovir disoproxil fumarate therapy to prevent hepatitis B virus vertical transmission-A review of maternal and infant outcomes.
Liver Int. 2022 Aug;42(8):1712-1730. doi: 10.1111/liv.15249. Epub 2022 Mar 31.
Liver Int. 2022.
PMID: 35312156
Review.
Hepatitis B virus (HBV) is a global health problem. Vertical transmission of HBV from HBV surface antigen (HBsAg)-positive mothers to their infants is the most common cause of HBV infection worldwide. ...Thus, it is recommended that pregnant women with HBV-DNA level …
Hepatitis B virus (HBV) is a global health problem. Vertical transmission of HBV from HBV surface antigen (HBsAg)-positive mot …
Cite